Litcius/Paper detail

Debate rages over Alzheimer’s drug lecanemab as UK limits approval

Diana Kwon

2024Nature14 citationsDOI

Topics & Concepts

European unionEuropean communityRegulatorDrug approvalPolitical scienceDrug developmentDrugMedicinePublic administrationBusinessPharmacologyInternational tradeBiologyBiochemistryGeneHealthcare Systems and ChallengesHealth Systems, Economic Evaluations, Quality of LifeHealth Services Management and Policy
Debate rages over Alzheimer’s drug lecanemab as UK limits approval | Litcius